BioInformant

Your Global Leader in Stem Cell Market Research

Advertise with BioInformant. We Reach Nearly a Million Targeted Readers Per Year.

Have you watched our audience size grow rapidly over the past few years and wondered how you could engage with it?

BioInformant’s audience includes:

Additionally, we are a Top Contribute in LinkedIn Groups where we can reach another 148,000+ readers on your behalf.

BioInformant also controls dozens of stem cell terms on Google (1st page results) and rank highly in AI-based Search (which drives high volumes of referral traffic).

Notably, our team has great expertise in Search Engine Optimization (SEO) and AI / Answer Engine Optimization (AEO), which means we are skillful at getting content ranked by Google and AI to drive continuous daily traffic.

BioInformant’s Domain Authority

Due to building credibility within the stem cell industry over the past 20 years since we were founded in 2006, BioInformant has very high Domain Authority (DA).

This is to say, the BioInformant website is well regarded and trusted within the industry, and it tends to rank very highly for its published content and graphics.

At present, BioInformant’s DA is 51, and the site has over 7,500+ backlinks (links from other sites that direct to it) from over 2,500+ referring domains.

Those numbers are highly unusual because they reflect decades of work spent building trust with Google Search and now AI, as well as trust within the industry itself to generate that large volume of backlinks.

From a technical perspective, domain authority (DA) is a logarithmic measure of a website’s overall SEO strength and credibility, based largely on the quality and quantity of sites linking to it. It matters because stronger domains tend to rank higher and more often within both AI answers and traditional search results. Because the DA scale is logarithmic, it is much harder to increase DA as a website moves into higher ranges, meaning that each additional point requires substantially more authority-building effort than the points before it.

You can see BioInformant’s current Domain Authority ranking here (or in the image below).

Options to reach our audience include:

  1. Press Release Publication

    While we have spent many years and over a million dollars to go our audience, you can reach it for only $297.

    For this small investment, we will publish your press release to BioInformant.com to reach nearly a million readers per year from across the stem cell industry.

    We will also share your news announcement across all of BioInformant’s audience channels, including to our large Social Media followings on LinkedIn, Twitter, and Facebook.

    Additionally, we will distribute it to our Email Subscribers (45,000+) and Push Notification (7,200+) Subscribers, as well as SEO optimize it to rank high in Google Search to drive continuous organic traffic every day.  

    Because this is a both a quick and cost effective way to access BioInformant’s large and targeted audience, we currently do Press Release Publication for nearly all of the leading companies within the stem cell sector.

    In short, you get access to BioInformant’s full audience (across all channels) that has taken us many years and over a million dollars to acquire and you will have created an “evergreen” asset for you company that will permanently live on our site.

    Learn how you can get know across the stem cell industry by clicking here. If you have further questions, email us at [email protected]

  2. Inclusion in Email Newsletter – Reaches 45,000+ Subscribers

    Inclusion in our weekly Email Newsletter is only $497 for a one-time inclusion or $797 for two inclusions (40% off the second inclusion) or $997 for three inclusions (an even greater discount).

    This includes a one-time placement of either a Banner Ad (600 x 150 px) or a Native Inclusion (which includes Title, Link, and 3-4 Sentence Short Description) about your company/product/event.

    Reach out to us at [email protected] to see examples or get your content included in our next Email Newsletter to 45,000+ stem cell industry subscribers.

    BioInformant Email Newsletter Example
    Example of BioInformant Email Newsletter Example

  3. Native Content

    This is another popular option. Sponsored Article to get your content published to our site, distributed across all of our audience channels, and both SEO and AEO optimized to rank high in Google Search and AI-based answers to drive referral traffic.

    Sponsored Interviews can also be published and distributed across all of BioInformant’s audience channels.

    Importantly, you get substantial credibility when a third-party releases news about your company.

    Please contact our Content Team at [email protected] check availability, request pricing, and schedule your content release date.

  4. Website Ads

    Because we want our site to remain focused on high-quality content, BioInformant offers extremely limited advertising to leaders within the stem cell and cell therapy fields.

    You can currently see square (400 x 400 px) ads in our left sidebar, as well as select inline ads within our articles.

    We are very rare as a publisher in that we do not rotate our ads, so if you are able to place one on our site, it will reach every single visitor.

    To inquire about ad availability, please email [email protected].

For additional questions about any of these options, we would love to hear from you at [email protected]. We look forward to introducing your company to our audience.

Shopping cart0
There are no products in the cart!
Continue shopping
0